Know a great AI tool or AI news source? Submit it to AiByts
fda3 min read

Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

Current gene-editing treatments require removal of a participant’s cells, a complex and costly approach.

By Heidi LedfordNature AI
Novel CRISPR therapy is poised to gain first FDA approval to alter genes inside the body

Read the full story

Originally published by Nature AI on Nov 12, 2026.

Read on Nature AI(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.